Penetration-enhanced Direct DBD Non-thermal Plasma for Hair Loss
Using Direct Non-thermal Atmospheric Pressure Plasma With Penetration Enhancement for the Treatment of Hair Loss
1 other identifier
interventional
19
1 country
1
Brief Summary
In-office applied non-thermal atmospheric pressure plasma treatment on NS pretreated scalp
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2023
CompletedFirst Submitted
Initial submission to the registry
November 20, 2023
CompletedFirst Posted
Study publicly available on registry
November 28, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 12, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 12, 2024
CompletedApril 17, 2024
April 1, 2024
7 months
November 20, 2023
April 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Presence of detectable hair growth
Presence of hair growth as measured using the HairMetrix device
3 months and 6 months
Secondary Outcomes (1)
Adverse effects related to the treatment
throughout study completeion, 6 months
Study Arms (1)
NTAP treatment
EXPERIMENTALTreatment arm subjects receive the trial intervention
Interventions
Cold plasma is generated and applied to the scalp area, which was previously soaked with normal saline
Eligibility Criteria
You may qualify if:
- diagnosis of mild-to moderate androgenetic alopecia
- ability to keep in-person follow-up appointments
You may not qualify if:
- any inflammatory scalp condition
- starting or discontinuing any hair loss treatments within 6 months of start date
- allergy to any components of the carrier solution
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Skin Center Dermatology Group
New City, New York, 10956, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- President
Study Record Dates
First Submitted
November 20, 2023
First Posted
November 28, 2023
Study Start
September 1, 2023
Primary Completion
April 12, 2024
Study Completion
April 12, 2024
Last Updated
April 17, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share